Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Complicated Skin And Skin Structure Infections (cSSSI) - Pipeline Review, H2 2012 - New Study Released


Print article Print article
2013-01-28 05:01:02 - New Pharmaceuticals market report from Global Markets Direct: "Complicated Skin And Skin Structure Infections (cSSSI) - Pipeline Review, H2 2012"

Global Markets Direct's, 'Complicated Skin And Skin Structure Infections (cSSSI) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Complicated Skin And Skin Structure Infections (cSSSI), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Complicated Skin And Skin Structure Infections (cSSSI). Complicated Skin And Skin Structure Infections (cSSSI) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report

Details at
- www.fastmr.com/prod/528058_complicated_skin_and_skin_structure_i ..


Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Complicated Skin And Skin Structure Infections (cSSSI).
* A review of the Complicated Skin And Skin Structure Infections (cSSSI) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Complicated Skin And Skin Structure Infections (cSSSI) pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Complicated Skin And Skin Structure Infections (cSSSI).
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Complicated Skin And Skin Structure Infections (cSSSI) pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Complicated Skin And Skin Structure Infections (cSSSI) Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Complicated Skin And Skin Structure Infections (cSSSI) 7
Complicated Skin And Skin Structure Infections (cSSSI) Therapeutics under Development by Companies 9
Late Stage Products 10
Comparative Analysis 10
Mid Clinical Stage Products 11
Comparative Analysis 11
Complicated Skin And Skin Structure Infections (cSSSI) Therapeutics - Products under Development by Companies 12
Companies Involved in Complicated Skin And Skin Structure Infections (cSSSI) Therapeutics Development 13
Takeda Pharmaceutical Company Limited 13
Rib-X Pharmaceuticals, Inc. 14
Paratek Pharmaceuticals, Inc. 15
Basilea Pharmaceutica Ltd. 16
CrystalGenomics, Inc. 17
Complicated Skin And Skin Structure Infections (cSSSI) - Therapeutics Assessment 18
Assessment by Monotherapy Products 18
Assessment by Route of Administration 19
Assessment by Molecule Type 21
Drug Profiles 23
ceftaroline fosamil - Drug Profile 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
omadacycline tosylate - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
delafloxacin - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
CG-400549 - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
JNJ-Q2 - Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
ceftobiprole medocaril - Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Complicated Skin And Skin Structure Infections (cSSSI) Therapeutics - Drug Profile Updates 37
Complicated Skin And Skin Structure Infections (cSSSI) Therapeutics - Dormant Products 43
Complicated Skin And Skin Structure Infections (cSSSI) - Product Development Milestones 44
Featured News & Press Releases 44
Aug 28, 2012: European Commission Approves Zinforo To Treat Skin Infections Or Community Acquired Pneumonia 44

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=528058&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser